Some CNAs overlapped between tumor types, others were tumor type-specific; losses of CDH20 and PTEN were observed in both tumor types, whereas amplifications seemed more tumor type-specific, such as EGFR and MAP2K4 in colon cancer and ERBB2 in breast cancer [16]. This evidence concerns the gene EGFR and neoplasm.